Physician profile
Mark Jason
NPI 1629179536
$4,793.59
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,569 · 2020: $810 · 2021: $1,337 · 2022: $77.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,441.85 | 2019-2022 | |
| Lilly USA, LLC | $1,014.51 | 2019-2022 | |
| Abbvie INC. | $673.99 | 2019-2021 | |
| Janssen Biotech, INC. | $440.01 | 2019-2021 | |
| Celgene Corporation | $273.16 | 2019 | |
| Pfizer INC. | $256.73 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $146.73 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $105.69 | 2019-2021 | |
| Genzyme Corporation | $94.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.98 | 2019-2020 | |
| Glaxosmithkline, LLC. | $71.20 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $66.85 | 2019 | |
| Horizon Therapeutics Plc | $48.43 | 2019-2020 | |
| Genentech USA, INC. | $40.27 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $28.98 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $15.77 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.